Published · Updated · SkinWise Clinic
PRP vs minoxidil for hair loss: evidence, burden and suitability
PRP and minoxidil are different interventions. Neither is the right default for every person with shedding. First establish whether the concern is pattern hair loss, temporary shedding, patchy loss or an inflammatory scalp condition.
What each option involves
Minoxidil is a medicine used in selected hair-loss plans. Topical application and oral prescribing have different suitability and risks. PRP is a procedure that prepares a platelet-rich portion of a person’s blood for injection into the scalp. Preparing blood does not make the procedure free of adverse effects.
| Decision | Minoxidil | PRP |
|---|---|---|
| Treatment burden | Ongoing use according to the selected formulation and prescription | Clinic procedures, with a proposed course and review |
| Evidence discussed here | Specific medicines and routes studied in male pattern loss | Studies of selected pattern-loss populations using varied methods |
| What to ask about | Tolerance, unwanted effects, pregnancy plans and how to assess response | Preparation, expected added benefit, discomfort and procedural risks |
| Maintenance | Continued treatment may be needed to maintain benefit | Durability and repeat-treatment needs are uncertain and vary |
What does the research support?
A 2022 network meta-analysis compared minoxidil and selected other medicines in men with androgenetic alopecia. Its rankings include indirect comparisons and do not choose a prescription for an individual. They cannot be transferred automatically to women, patchy autoimmune loss or temporary shedding.
A 2024 systematic review of PRP found possible improvement in male pattern loss but substantial limitations from bias and variation in preparation and study methods. It does not support promising a fixed session count, a particular number of months of benefit or equivalent effects from GFC and mesotherapy.
Is combining them always better?
Not established by these separate reviews. A combined plan needs a clear reason, relevant evidence and an assessment of added benefit versus cost and treatment burden. Ask how you will know whether the additional procedure helped and when the plan will be reviewed. “Both” should not be the automatic answer before diagnosis.
Side effects and suitability matter
Discuss scalp irritation and unwanted hair growth with topical treatment, and the separate systemic risks and monitoring relevant to oral medicines. Share your full medicine list, health conditions, pregnancy or breastfeeding plans. For PRP, ask about pain, bleeding, bruising, infection risk and factors that could make the procedure unsuitable. AAD treatment guidance.
If shedding becomes unexpected, prolonged or accompanied by scalp symptoms, seek reassessment rather than assuming it proves treatment is working. Do not switch medicine routes, doses or repeat procedures based on a generic calendar.
Before making a choice
Bring previous photographs, prescriptions, supplement labels and relevant reports to a hair-loss consultation. Agree what response is realistic, how it will be measured, what maintenance might involve and which symptoms need contact. The hair-fall assessment guide can help organise that history.